Loading clinical trials...
Loading clinical trials...
Anti-angiogenic therapy is an important treatment strategy for recurrent glioblastoma. Our previous study provided evidence for a potential benefit of apatinib, a humanized monoclonal antibody against...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beijing Sanbo Brain Hospital
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT07003542 · Glioblastoma, Brain Tumor
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT07274397 · Glioblastoma, Brain Tumors, and more
Capital Medical University Sanbo Brain Hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions